Articles from Incubate

Washington, DC, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab released insights from a survey of life sciences venture capital (VC) investors showing that policy -- not just scientific potential -- is playing an increasing role in how investors assess biotech opportunities. In other words, VCs aren't just watching the science; they're watching Washington.

Executives also cite NIH and FDA uncertainty, external reference pricing, tariffs, and research funding cuts as major threats

Washington, DC, March 05, 2025 (GLOBE NEWSWIRE) -- This week, Senators Thom Tillis (R-NC), Ted Budd (R-NC), Marsha Blackburn (R-TN), James Lankford (R-OK), and Steve Daines (R-MT) introduced the Ensuring Pathways to Innovative Cures (EPIC) Act, which would amend the Inflation Reduction Act to give all drugs the same 13-year exemption from price controls following FDA approval.

Washington, DC, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Today, Representative Greg Murphy, Representative Don Davis, and Representative Richard Hudson reintroduced the bipartisan Ensuring Pathways to Innovative Cures (EPIC) Act, which would amend the Inflation Reduction Act to provide newly approved small-molecule drugs and biologics the same 13-year exemption from price controls.

Washington, DC, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab released insights from a survey of life sciences venture capital investors about how the Inflation Reduction Act and other U.S. healthcare policy developments impact their decisions to invest in biotech startups.

Washington, DC, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Today, Incubate launched the "Small Molecules, Big Voices" video series to illustrate the importance of small molecule drugs to patients, investors, and policymakers.

Washington, DC, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Today, the Biden administration announced Maximum Fair Prices (MFPs) for the first 10 drugs selected for Medicare price setting under the Inflation Reduction Act.

Washington, DC, May 01, 2024 (GLOBE NEWSWIRE) -- Today, Incubate launched a six-figure advertising campaign across North Carolina commending Representatives Greg Murphy (R-NC) and Don Davis (D-NC) for working across party lines to introduce the Ensuring Pathways to Innovative Cures (EPIC) Act.

Washington, DC, April 26, 2024 (GLOBE NEWSWIRE) -- Today, on World Intellectual Property Day, Incubate is excited to launch Incubate Policy Lab under the guidance of senior advisor Kirsten Axelsen. Kirsten brings over two decades of leadership experience in the life sciences industry. Accompanying the launch is a new white paper examining the important role intellectual property protections play in biopharmaceutical development.

Washington, DC, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Today, the Centers for Medicare & Medicaid Services announced the first 10 Medicare Part D drugs selected for government price setting under the Inflation Reduction Act.